Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting

ABSTRACT: Active surveillance (AS) in the management of small, low risk papillary thyroid cancer (PTC) as an alternative option to thyroidectomy, is an area of active research. A national Canadian study is proposed to evaluate the long-term outcomes of patients with small, low risk PTC who choose AS...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, David P., Ghai, Sangeet, Corsten, Martin, Bissada, Eric, Audet, Nathalie, Zhang, Han, Nichols, Anthony, Morrison, Deric, Johnson-Obeski, Stephanie, Anderson, Donald W., Prisman, Eitan, Baxter, Nancy N., Jones, Jennifer, Gafni, Amiram, Witterick, Ian, Sawka, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228934/
https://www.ncbi.nlm.nih.gov/pubmed/34172096
http://dx.doi.org/10.1186/s40463-021-00514-0
_version_ 1783712858293403648
author Goldstein, David P.
Ghai, Sangeet
Corsten, Martin
Bissada, Eric
Audet, Nathalie
Zhang, Han
Nichols, Anthony
Morrison, Deric
Johnson-Obeski, Stephanie
Anderson, Donald W.
Prisman, Eitan
Baxter, Nancy N.
Jones, Jennifer
Gafni, Amiram
Witterick, Ian
Sawka, Anna M.
author_facet Goldstein, David P.
Ghai, Sangeet
Corsten, Martin
Bissada, Eric
Audet, Nathalie
Zhang, Han
Nichols, Anthony
Morrison, Deric
Johnson-Obeski, Stephanie
Anderson, Donald W.
Prisman, Eitan
Baxter, Nancy N.
Jones, Jennifer
Gafni, Amiram
Witterick, Ian
Sawka, Anna M.
author_sort Goldstein, David P.
collection PubMed
description ABSTRACT: Active surveillance (AS) in the management of small, low risk papillary thyroid cancer (PTC) as an alternative option to thyroidectomy, is an area of active research. A national Canadian study is proposed to evaluate the long-term outcomes of patients with small, low risk PTC who choose AS or surgery. This letter describes the proceedings of a national investigator meeting to plan the study. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-8228934
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82289342021-06-28 Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting Goldstein, David P. Ghai, Sangeet Corsten, Martin Bissada, Eric Audet, Nathalie Zhang, Han Nichols, Anthony Morrison, Deric Johnson-Obeski, Stephanie Anderson, Donald W. Prisman, Eitan Baxter, Nancy N. Jones, Jennifer Gafni, Amiram Witterick, Ian Sawka, Anna M. J Otolaryngol Head Neck Surg Letter to the Editor ABSTRACT: Active surveillance (AS) in the management of small, low risk papillary thyroid cancer (PTC) as an alternative option to thyroidectomy, is an area of active research. A national Canadian study is proposed to evaluate the long-term outcomes of patients with small, low risk PTC who choose AS or surgery. This letter describes the proceedings of a national investigator meeting to plan the study. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2021-06-25 /pmc/articles/PMC8228934/ /pubmed/34172096 http://dx.doi.org/10.1186/s40463-021-00514-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Goldstein, David P.
Ghai, Sangeet
Corsten, Martin
Bissada, Eric
Audet, Nathalie
Zhang, Han
Nichols, Anthony
Morrison, Deric
Johnson-Obeski, Stephanie
Anderson, Donald W.
Prisman, Eitan
Baxter, Nancy N.
Jones, Jennifer
Gafni, Amiram
Witterick, Ian
Sawka, Anna M.
Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting
title Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting
title_full Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting
title_fullStr Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting
title_full_unstemmed Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting
title_short Proceedings of the Canadian Thyroid Cancer Active Surveillance Study Group 2019 national investigator meeting
title_sort proceedings of the canadian thyroid cancer active surveillance study group 2019 national investigator meeting
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228934/
https://www.ncbi.nlm.nih.gov/pubmed/34172096
http://dx.doi.org/10.1186/s40463-021-00514-0
work_keys_str_mv AT goldsteindavidp proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT ghaisangeet proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT corstenmartin proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT bissadaeric proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT audetnathalie proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT zhanghan proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT nicholsanthony proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT morrisonderic proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT johnsonobeskistephanie proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT andersondonaldw proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT prismaneitan proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT baxternancyn proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT jonesjennifer proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT gafniamiram proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT witterickian proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting
AT sawkaannam proceedingsofthecanadianthyroidcanceractivesurveillancestudygroup2019nationalinvestigatormeeting

Ejemplares similares